| abstract |
The invention provides compounds of Formula (I): n n n wherein: R 1 -R 5 , A, L, and X have any of the values defined in the specification that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use, and methods and intermediates useful for preparing them. |